1. CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial. (3rd July 2018) Authors: Wang, Yao; Chen, Meixia; Wu, Zhiqiang; Tong, Chuan; Dai, Hanren; Guo, Yelei; Liu, Yang; Huang, Jianhua; Lv, Haiyan; Luo, Can; Feng, Kai-chao; Yang, Qing-ming; Li, Xiao-lei; Han, Weidong Journal: Oncoimmunology Issue: Volume 7:Number 7(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects. (21st February 2016) Authors: Guo, Yelei; Wang, Yao; Han, Weidong Other Names: Blaser Kurt Academic Editor. Journal: Journal of immunology research Issue: Volume 2016(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia. Issue 1 (December 2016) Authors: Cai, Bo; Guo, Mei; Wang, Yao; Zhang, Yajing; Yang, Jun; Guo, Yelei; Dai, Hanren; Yu, Changlin; Sun, Qiyun; Qiao, Jianhui; Hu, Kaixun; Zuo, Hongli; Dong, Zheng; Zhang, Zechuan; Feng, Mingxing; Li, Bingxia; Sun, Yujing; Liu, Tieqiang; Liu, Zhiqing; Wang, Yi Journal: Journal of hematology & oncology Issue: Volume 9:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment. Issue 12 (2nd May 2017) Authors: Wang, Zhenguang; Guo, Yelei; Han, Weidong Journal: Protein & cell Issue: Volume 8:Issue 12(2017) Page Start: 896 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cytokine‐induced killer (CIK) cells: from basic research to clinical translation. Issue 3 (5th March 2015) Authors: Guo, Yelei; Han, Weidong Journal: Cancer communications Issue: Volume 34:Issue 3(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effective and persistent antitumor activity of HER2-directed CAR-T cells against gastric cancer cells in vitro and xenotransplanted tumors in vivo. Issue 10 (10th March 2017) Authors: Song, Yanjing; Tong, Chuan; Wang, Yao; Gao, Yunhe; Dai, Hanren; Guo, Yelei; Zhao, Xudong; Wang, Yi; Wang, Zizheng; Han, Weidong; Chen, Lin Journal: Protein & cell Issue: Volume 9:Issue 10(2018) Page Start: 867 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and biomarker analysis of CD133-directed CAR T cells in advanced hepatocellular carcinoma: a single-arm, open-label, phase II trial. (1st January 2020) Authors: Dai, Hanren; Tong, Chuan; Shi, Daiwei; Chen, Meixia; Guo, Yelei; Chen, Deyun; Han, Xiao; Wang, Hua; Wang, Yao; Shen, Pingping Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Mutant B2M‐HLA‐E and B2M‐HLA‐G fusion proteins protects universal chimeric antigen receptor‐modified T cells from allogeneic NK cell‐mediated lysis. Issue 10 (19th August 2021) Authors: Guo, Yelei; Xu, Beilei; Wu, Zhiqiang; Bo, Jian; Tong, Chuan; Chen, Deyun; Wang, Jin; Wang, Haoyi; Wang, Yao; Han, Weidong Journal: European journal of immunology Issue: Volume 51:Issue 10(2021) Page Start: 2513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PD-1 silencing impairs the anti-tumor function of chimeric antigen receptor modified T cells by inhibiting proliferation activity. Issue 1 (7th August 2019) Authors: Wei, Jianshu; Luo, Can; Wang, Yao; Guo, Yelei; Dai, Hanren; Tong, Chuan; Ti, Dongdong; Wu, Zhiqiang; Han, Weidong Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers. Issue 10 (14th July 2017) Authors: Feng, Kaichao; Liu, Yang; Guo, Yelei; Qiu, Jingdan; Wu, Zhiqiang; Dai, Hanren; Yang, Qingming; Wang, Yao; Han, Weidong Journal: Protein & cell Issue: Volume 9:Issue 10(2018) Page Start: 838 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗